Cargando…

2797. Antimicrobial Photodynamic Therapy (aPDT) Is Highly Effective Against Multidrug-Resistant HA- and CA- S. aureus Strains

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is often associated with multidrug-resistant (MDR) infections found in healthcare settings, resulting in 48,000 deaths in the US and 1.27 million deaths worldwide each year. S. aureus strains are a common component of nasal microbiota an...

Descripción completa

Detalles Bibliográficos
Autores principales: Romo_Bernal, Cristina P, Chavez, Micah, Levengood, Sheeny, Sabino, Caetano, Loebel, Nicolas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678795/
http://dx.doi.org/10.1093/ofid/ofad500.2408
Descripción
Sumario:BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is often associated with multidrug-resistant (MDR) infections found in healthcare settings, resulting in 48,000 deaths in the US and 1.27 million deaths worldwide each year. S. aureus strains are a common component of nasal microbiota and can be disseminated by both patients and healthcare workers, posing a substantial hospital-acquired infection risk. Antimicrobial photodynamic therapy (aPDT) combines the use of a photosensitizer (PS) with a specific wavelength of light to induce photochemical reactions lethal to a broad spectrum of microbes, without resistance induction. The objective of this study was to demonstrate the efficacy of aPDT against clinically-relevant multidrug-resistant S. aureus strains using a commercially-available photosensitizer formulation (Steriwave(TM), Ondine Biomedical Inc., Vancouver, BC). Resistance profile of MRSA strains [Figure: see text] METHODS: The MRSA strains used in this study included confirmed resistance to: cefoxitin, clindamycin, erythromycin, levofloxacin, mupirocin, oxacillin, penicillin, rifampicin, novobiocin, tetracyclines, trimethoprim/sulfamethoxazole, gentamicin, chloramphenicol, ciprofloxacin, moxifloxacin, linezolid, tedizolid quinupristin/dalfopristin and mupirocin. aPDT was carried out by exposing planktonic suspensions of each strain to photosensitizer formulations containing either 0.01% MB or Steriwave(TM) (0.01% MB and 0.25% chlorhexidine gluconate in an aqueous excipient base). Illumination was performed at 670 nm, 150 mW/cm(2) for 60 s (9 J/cm(2)). Samples were serially diluted and plated on TSA for CFU counting RESULTS: Relative to untreated controls, aPDT resulted in a minimum reduction of 3log(10) (99.9%) against all MRSA strains tested, with the commercial Steriwave(TM) formulation producing an average of 10X greater kills than aqueous methylene blue under the same illumination parameters. CONCLUSION: aPDT is highly effective against a variety of clinically-relevant multidrug-resistant S. aureus strains in 60 s of treatment. The technique represents a promising alternative to antibiotics in healthcare systems where antimicrobial resistance strategies are important DISCLOSURES: Nicolas G. Loebel, PhD, ONDINE Biomedical Inc.: Board Member|ONDINE Biomedical Inc.: Employee|ONDINE Biomedical Inc.: Stocks/Bonds